Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 165, Issue -, Pages 115179
Publisher
Elsevier BV
Online
2023-07-21
DOI
10.1016/j.biopha.2023.115179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
- (2023) Jiaxin Zhang et al. Advanced Science
- FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
- (2023) Yifan Liu et al. Journal of Translational Medicine
- Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
- (2022) Nisha Kumari et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Development of Pharmaceutical Nanomedicines: From the Bench to the Market
- (2022) Abdulrahman A. Halwani Pharmaceutics
- Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming
- (2022) Ting Zhao et al. Acta Biomaterialia
- Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
- (2022) Hongyi Chen et al. BIOMATERIALS
- Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
- (2022) Philip A. Philip et al. CLINICAL CANCER RESEARCH
- Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
- (2022) Stavros P. Papadakos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ
- (2022) Yi Liu et al. Nature Communications
- Current approaches of nanomedicines in the market and various stage of clinical translation
- (2022) Xiaoting Shan et al. Acta Pharmaceutica Sinica B
- Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
- (2022) Muhammad R. Haque et al. Microsystems & Nanoengineering
- Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma
- (2022) Biaoming Xu et al. INTERNATIONAL JOURNAL OF CANCER
- Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2022) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
- (2022) Ying Zhang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
- (2022) Muhammad Usman Munir Cancers
- Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
- (2022) Wanxing Duan et al. Frontiers in Oncology
- Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
- (2022) Juanjuan Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Vascularized pancreas-on-a-chip device produced using a printable simulated extracellular matrix
- (2022) Monika Hospodiuk-Karwowski et al. Biomedical Materials
- Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry
- (2022) Jordan Santucci et al. EUROPEAN JOURNAL OF CANCER
- Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
- (2022) Hailong Tian et al. Journal of Hematology & Oncology
- Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy
- (2022) Na Yu et al. NANO LETTERS
- Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy
- (2022) Weixin Zhou et al. Pharmaceutics
- Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
- (2022) Wanting Hou et al. Pharmaceutics
- Liposome-based diagnostic and therapeutic applications for pancreatic cancer
- (2022) Faisal Raza et al. Acta Biomaterialia
- PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk
- (2022) Viola Sgarminato et al. Biomaterials Science
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
- (2021) Alex Cazes et al. CLINICAL CANCER RESEARCH
- Ex vivo culture of intact human patient derived pancreatic tumour tissue
- (2021) John Kokkinos et al. Scientific Reports
- The CXCL12 Crossroads in Cancer Stem Cells and Their Niche
- (2021) Juan Carlos López-Gil et al. Cancers
- pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer
- (2021) Feng Fan et al. ACS Applied Materials & Interfaces
- KRAS drives immune evasion in a genetic model of pancreatic cancer
- (2021) Irene Ischenko et al. Nature Communications
- The Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
- (2021) Donatella Delle Cave et al. Cancers
- Smart transformable nanomedicines for cancer therapy
- (2021) Yuequan Wang et al. BIOMATERIALS
- Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
- (2021) Iris Lodewijk et al. Clinical Epigenetics
- Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy
- (2021) Xiaozheng Zhao et al. ACS Nano
- Modeling pancreatic cancer in mice for experimental therapeutics
- (2021) Kavita Mallya et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy
- (2021) Despina Siolas et al. Cell Reports
- Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
- (2021) Muhammad R. Haque et al. Cancers
- Targeting the Stroma in the Management of Pancreatic Cancer
- (2021) Penelope Edwards et al. Frontiers in Oncology
- Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy
- (2021) Shuwen Cao et al. BIOMATERIALS
- Hybrid artificial cell-mediated epigenetic inhibition in metastatic lung cancer
- (2021) Qingsheng Peng et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
- (2021) Enyong Dai et al. Molecular Cancer
- Hyaluronic acid nanoparticle-encapsulated microRNA-125b repolarizes tumor-associated macrophages in pancreatic cancer
- (2021) Neha N Parayath et al. Nanomedicine
- Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
- (2021) David Osuna de la Peña et al. Nature Communications
- Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy
- (2021) Ming Jia et al. JOURNAL OF NANOBIOTECHNOLOGY
- Artificial exosomes mediated spatiotemporal-resolved and targeted delivery of epigenetic inhibitors
- (2021) Huan Li et al. JOURNAL OF NANOBIOTECHNOLOGY
- Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
- (2021) Michelle K. Greene et al. Cancers
- CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
- (2021) Shivani Malik et al. Cancers
- Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
- (2021) Beate Gündel et al. Frontiers in Cell and Developmental Biology
- Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening
- (2021) Marlene Geyer et al. Frontiers in Cell and Developmental Biology
- Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
- (2021) Lennart Versemann et al. Visceral Medicine
- Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy
- (2020) Ying Xie et al. ACS Nano
- Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy
- (2020) Haijie Han et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma
- (2020) Michael J. Bradney et al. Small
- Magnetic Targeting and Ultrasound Activation of Liposome–Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies
- (2020) Pankaj Dwivedi et al. ACS Applied Materials & Interfaces
- Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer
- (2020) Jingxian Feng et al. BIOMATERIALS
- Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy
- (2020) Qianwen Yu et al. JOURNAL OF CONTROLLED RELEASE
- Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy
- (2020) Man Li et al. JOURNAL OF CONTROLLED RELEASE
- Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
- (2020) Yuanjun Lu et al. Molecular Cancer
- Challenges in nanomedicine clinical translation
- (2020) Josbert M. Metselaar et al. Drug Delivery and Translational Research
- 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
- (2020) Nancy D. Ebelt et al. Frontiers in Immunology
- Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
- (2020) Shunda Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
- (2020) Honglin Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency
- (2020) Di Chen et al. JOURNAL OF CONTROLLED RELEASE
- Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors
- (2020) Matthew I. Confeld et al. MOLECULAR PHARMACEUTICS
- Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
- (2020) Bin Tu et al. Frontiers in Cell and Developmental Biology
- Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes
- (2020) Alsya J. Affandi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
- (2020) Elisa Espinet et al. Cancer Discovery
- Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
- (2020) Bolun Jiang et al. Frontiers in Oncology
- Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
- (2020) Wenxi Zhou et al. BIOMATERIALS
- Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
- (2020) Verona Buocikova et al. Cancers
- Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
- (2020) M.E. Lorkowski et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the treatment of pancreatic cancer
- (2020) Yongho Jang et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1–/FOXM1+ Triple Negative Breast Cancer Cells
- (2019) Bumjun Kim et al. MOLECULAR PHARMACEUTICS
- Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment
- (2019) Esma Alp et al. International Journal of Nanomedicine
- EZH2 inhibitor GSK126 suppresses anti-tumor immunity by driving production of myeloid-derived suppressor cells
- (2019) Shuo Huang et al. CANCER RESEARCH
- A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients
- (2019) Yasuhiro Fujiwara et al. BRITISH JOURNAL OF CANCER
- TAMing pancreatic cancer: combat with a double edged sword
- (2019) Manendra Babu Lankadasari et al. Molecular Cancer
- Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer
- (2019) Xinli Chen et al. NANO LETTERS
- Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
- (2019) Gabriele D’Errico et al. ONCOGENE
- Gold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence
- (2019) Md. Nazir Hossen et al. ACS Applied Materials & Interfaces
- Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
- (2019) Sheema Khan et al. BIOMATERIALS
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
- (2019) Hua Huang et al. NANO LETTERS
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
- (2019) Hongliang He et al. ACCOUNTS OF CHEMICAL RESEARCH
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
- (2019) Duc-Huy T. Nguyen et al. Science Advances
- Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy
- (2019) Mengjie Gu et al. ACS Applied Materials & Interfaces
- Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer
- (2019) Ezequiel J Tolosa et al. GUT
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
- (2019) Gwen Lomberk et al. Nature Communications
- Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer
- (2019) Song Shang et al. Cancer Medicine
- Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
- (2019) Hongwei Sun et al. Frontiers in Immunology
- Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Vincent P. Groot et al. ANNALS OF SURGERY
- Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
- (2018) Jun Zhao et al. BIOMATERIALS
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
- (2018) Dietrich A. Ruess et al. NATURE MEDICINE
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma
- (2018) Ting Jiang et al. Artificial Cells Nanomedicine and Biotechnology
- Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells
- (2018) Sivakumar Vijayaraghavalu et al. Drug Delivery and Translational Research
- Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Zhi Rong Qian et al. JAMA Oncology
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2018) Karen A. Autio et al. JAMA Oncology
- Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
- (2018) Limei Shen et al. ACS Nano
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- Pancreatic cancer stem cells: A state or an entity?
- (2018) Patrick C. Hermann et al. SEMINARS IN CANCER BIOLOGY
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
- (2018) Derya Kabacaoglu et al. Frontiers in Immunology
- Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors
- (2018) Zhenghui Liu et al. Expert Review of Anticancer Therapy
- Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
- (2018) Deby F. Mardhian et al. JOURNAL OF CONTROLLED RELEASE
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
- (2018) Andrew McGuigan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
- (2017) Nai-Ming Chen et al. GASTROENTEROLOGY
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
- (2017) Aleksandra Adamska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
- (2017) WG Singleton et al. International Journal of Nanomedicine
- Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs
- (2017) Jieni Xu et al. JOURNAL OF DRUG TARGETING
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
- (2017) Pascal Syren et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon
- (2017) Yi-Dong Hong et al. Oncotarget
- Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy
- (2017) Hima Bindu Ruttala et al. Oncotarget
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration
- (2016) Hong-Jun Li et al. ACS Nano
- Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
- (2016) Christopher J. Tape et al. CELL
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- The Significance of Ras Activity in Pancreatic Cancer Initiation
- (2016) Craig D. Logsdon et al. International Journal of Biological Sciences
- Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography
- (2016) Marie K. Gurka et al. JOURNAL OF CONTROLLED RELEASE
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies
- (2016) Bruno Sainz et al. MEDIATORS OF INFLAMMATION
- EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
- (2016) Amit Singh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer
- (2016) Yang Li et al. Small
- The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer
- (2016) Hai Hu et al. TUMOR BIOLOGY
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts
- (2016) Andrew H. Nguyen et al. Oncotarget
- Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
- (2016) Keisuke Yamamoto et al. Oncotarget
- α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (KrasG12D, and KrasG12D/tp53R270H) mice
- (2016) Raj Kumar Verma et al. Scientific Reports
- Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer
- (2015) Kai Xiao et al. BIOMATERIALS
- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells
- (2015) Shiro Kohi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation
- (2015) Michel DuPage et al. IMMUNITY
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
- (2015) Hong Zong et al. ChemistryOpen
- Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
- (2015) Michael J. Thompson et al. PLoS One
- Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer
- (2014) Renu Sankar et al. BIOMEDICINE & PHARMACOTHERAPY
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells
- (2014) Tuan Hiep Tran et al. CARBOHYDRATE POLYMERS
- Lipid based nanocarrier system for the potential oral delivery of decitabine: Formulation design, characterization, ex vivo, and in vivo assessment
- (2014) Yub Raj Neupane et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer
- (2014) Prajakta S. Kulkarni et al. MOLECULAR PHARMACEUTICS
- α-Mangostin: A Dietary Antioxidant Derived from the Pericarp of Garcinia mangostana L. Inhibits Pancreatic Tumor Growth in Xenograft Mouse Model
- (2013) Bilal Bin Hafeez et al. ANTIOXIDANTS & REDOX SIGNALING
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
- (2012) Jianhua Ling et al. CANCER CELL
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
- (2012) R. Shakya et al. CANCER RESEARCH
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Multistage nanoparticle delivery system for deep penetration into tumor tissue
- (2011) C. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pancreatic cancerDNMT1expression and sensitivity toDNMT1inhibitors
- (2010) Ang Li et al. CANCER BIOLOGY & THERAPY
- Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
- (2009) Corey J. Langer et al. Journal of Thoracic Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More